RA CAPITAL MANAGEMENT, LLC Insider Trading for July 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for RA CAPITAL MANAGEMENT, LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of RA CAPITAL MANAGEMENT, LLC for July 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 29 2020 | ITOS | iTeos Therapeutics ... | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Option Exercise | C | 0.00 | 9,751,773 | 0 | 0 | |
| Jul 29 2020 | ITOS | iTeos Therapeutics ... | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Buy | P | 19.00 | 1,425,000 | 27,075,000 | 4,417,259 | 3 M to 4.4 M (+47.62 %) |
| Jul 29 2020 | ITOS | iTeos Therapeutics ... | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Buy | C | 0.00 | 2,992,259 | 0 | 2,992,259 | 0 to 3 M |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Option Exercise | C | 0.00 | 10,489,510 | 0 | 0 | |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Buy | P | 16.00 | 600,000 | 9,600,000 | 2,003,653 | 1.4 M to 2 M (+42.75 %) |
| Jul 28 2020 | INZY | Inozyme Pharma, In ... | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Buy | C | 0.00 | 1,403,653 | 0 | 1,403,653 | 0 to 1.4 M |
| Jul 22 2020 | PAND | Pandion Therapeuti ... | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Option Exercise | C | 0.00 | 7,184,596 | 0 | 0 | |
| Jul 22 2020 | PAND | Pandion Therapeuti ... | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Buy | P | 18.00 | 361,111 | 6,499,998 | 1,770,023 | 1.4 M to 1.8 M (+25.63 %) |
| Jul 22 2020 | PAND | Pandion Therapeuti ... | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Buy | C | 0.00 | 1,408,912 | 0 | 1,408,912 | 0 to 1.4 M |
| Jul 16 2020 | NKTX | Nkarta, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Option Exercise | C | 0.00 | 8,405,656 | 0 | 0 | |
| Jul 16 2020 | NKTX | Nkarta, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Buy | P | 18.00 | 3,333,333 | 59,999,994 | 5,605,129 | 2.3 M to 5.6 M (+146.73 %) |
| Jul 16 2020 | NKTX | Nkarta, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Buy | C | 0.00 | 2,271,796 | 0 | 2,271,796 | 0 to 2.3 M |
| Jul 10 2020 | ETNB | 89bio, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | P | 27.50 | 275,000 | 7,562,500 | 3,436,214 | 3.2 M to 3.4 M (+8.70 %) |
| Jul 02 2020 | RYTM | RHYTHM PHARMACEUTI ... | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Sell | S | 22.04 | 44,153 | 972,969 | 5,140,408 | 5.2 M to 5.1 M (-0.85 %) |
| Jul 02 2020 | RYTM | RHYTHM PHARMACEUTI ... | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Sell | S | 21.87 | 25,527 | 558,311 | 5,184,561 | 5.2 M to 5.2 M (-0.49 %) |
| Jul 02 2020 | RYTM | RHYTHM PHARMACEUTI ... | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Sell | S | 22.15 | 61,901 | 1,371,237 | 5,210,088 | 5.3 M to 5.2 M (-1.17 %) |